CompletedNot Applicable

Evaluation of Oxygen Delivery Methods in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)

Turkey (Türkiye)100 participantsStarted 2023-11-01

Plain-language summary

To examine the effects of oxygen therapy methods applied as indicated in COPD acute exacerbations on blood gas results and spirometric measurements.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with acute exacerbation of COPD, * Those without a history of trauma, * Patients who have not undergone any lung surgery previously, * Patients capable of providing written and verbal consent. Exclusion Criteria: * Patients without acute exacerbation of COPD, * Pregnancy, suspected pregnancy, * Those who have undergone any lung surgery previously, * Patients with a history of trauma, * Intubated patients and those not compliant with treatments, * Patients unable to provide written and verbal consent.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Arterial blood gas and spirometry values will be examined before and after treatment administration to patients.

Timeframe: Patients will receive 2-hour treatment (EzPAP and NIMV) and then measurements will be taken 30 minutes after the completion of treatment in both groups.

Evaluation of the patient's mortalite after treatment.

Timeframe: The 30-day mortality of the patients will be evaluated.

Trial details

NCT IDNCT06561464

SponsorAnkara Etlik City Hospital

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2024-04-30

View on ClinicalTrials.gov More Chronic Obstructive Pulmonary Disease Exacerbation trials